Products - Diabetes | Topic | NICE

Showing 6 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
Status: In developmentRemove ‘Status: In development’ filter

Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Cardiometabolic disease prevention and treatment guidelines
Status:
In development
Programme:
NICE Hub
Expected publication date:
TBC
Diabetic retinopathy - ruboxistaurin [ID382]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Insulin icodec for treating type 2 diabetes [ID6175]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
21 May 2025
Teplizumab for delaying the onset of type 1 diabetes in people 8 years and over at risk of developing the condition [ID6259]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Type 2 diabetes in adults: management (medicines update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
19 June 2025